T. Bodvarsdottir

发表

Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.

J. Sturis, C. Fledelius, R. Alemzadeh, 2004, Metabolism: clinical and experimental.

Synthesis and pharmacological evaluation of 4H-1,4-benzothiazine-2-carbonitrile 1,1-dioxide and N-(2-cyanomethylsulfonylphenyl)acylamide derivatives as potential activators of ATP sensitive potassium channels.

P. Arkhammar, P. Wahl, M. Antoine, 2005, Bioorganic & medicinal chemistry.

Quality of plasma sampled by different methods for multiple blood sampling in mice

A. Hansen, L. F. Mikkelsen, A. K. Hansen, 2009, Laboratory animals.

New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.

A. F. Jensen, P. Arkhammar, P. Wahl, 2006, Journal of medicinal chemistry.

Subdiaphragmatic vagal deafferentation affects body weight gain and glucose metabolism in obese male Zucker (fa/fa) rats.

G. Pacini, W. Langhans, R. Carr, 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.

P. Arkhammar, P. Wahl, P. Mackay, 2002, Journal of medicinal chemistry.

NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat.

J. Sturis, R. Carr, C. L. Brand, 2003, Diabetes.

Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.

J. Holst, G. Lowe, A. Rumley, 2011, Diabetes research and clinical practice.

Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus

L. B. Knudsen, A. Karlsen, R. Heller, 2010, Regulatory Peptides.

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders.

P. Arkhammar, P. Wahl, J. Hansen, 2004, Current medicinal chemistry.

Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus—an adaptive response to hyperglycaemia?

J. Holst, K. Maedler, A. Karlsen, 2011, Diabetologia.